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Effect of phosphodiesterase-5 inhibition on joint and muscle damage in rats with
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Background/aim: This study was designed to examine the effect of tadalafil, a phosphodiesterase (PDE)5 inhibitor, on the severity of
joint and muscle damage in rats with adjuvant-induced arthritis (AA).
Materials and methods: AA was induced by intradermal inoculation into right hind paw of male Sprague Dawley rats (300–450
g) with complete Freund’s adjuvant (CFA; 0.1 mL). AA rats were treated with either tadalafil (10 mg/kg; per oral) alone or along
with the soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 10 mg/kg; intraperitoneally). After
decapitation on day 16, trunk blood was collected for total oxidant status (TOS) and total antioxidant capacity (TAC) assays. The left
metatarsophalangeal joint and gastrocnemius muscle were excised for microscopic examination. Muscle samples were also evaluated in
terms of malondialdehyde (MDA), glutathione, and chemiluminescence (CL) levels.
Results: In tadalafil-treated AA rats, metatarsophalangeal joints revealed regular morphology of the cartilage with slight destruction
and less inflammatory cell infiltration and vascularization in comparison to the controls (microscopic score: 1.17 ± 0.31 vs. 4.17 ± 0.79;
P < 0.01). AA rats presented increased gastrocnemius muscle MDA, glutathione, and CL levels compared to the controls (P < 0.01, for
MDA; P < 0.05, for glutathione; P < 0.05 for CL). Tadalafil attenuated the increase in CL levels (P < 0.01, for luminol and P < 0.001, for
lucigenin). Serum TOS showed significant reductions by tadalafil.
Conclusion: The long-acting PDE5 inhibitor tadalafil provides partial protection in a rat model of CFA-induced arthritis possibly via
suppression of oxidant generation.
Key words: Arthritis, phosphodiesterase-5, rat, tadalafil

1. Introduction
Rheumatoid arthritis is a chronic, inflammatory, and
systemic autoimmune disorder characterized by synovial
inflammation and destruction of cartilage and bone. The
etiopathogenesis of the disease includes the inflammatory
cytokines (e.g., tumor necrosis factor-α, interleukin-1β,
and interleukin-6) and inflammatory mediators (e.g.,
cyclooxygenases and lipoxygenases) (1). Studies have
shown the presence of neutrophils in the synovial fluid
and on the pannus–cartilage interface in arthritis (2,3).
Isolated neutrophils from arthritic patients showed
priming that may be related to the presence of proinflammatory cytokines in the synovial fluid (4). Thus, the
activated neutrophils may contribute to joint destruction
through the release of reactive oxygen species (ROS).
Cachexia has also been reported in rheumatoid
arthritis patients and seems to be an important contributor
* Correspondence: incialican@yahoo.com

in increasing morbidity and mortality (5). Although
experimental chronic arthritis induces anorexia, the
weight loss and muscle wasting observed in animals with
arthritis were not found to be associated with decrease in
food intake. Instead, the muscle wasting was mostly due to
systemic inflammation (6).
Phosphodiesterases (PDEs) are metallohydrolases
that catalyze the breakdown of cyclic adenosine
monophosphate
(cAMP)
or
cyclic
guanosine
monophosphate (cGMP) into the inactive 5′-AMP or
GMP, thereby regulating the duration and amplitude of
cyclic nucleotide signaling. PDEs comprise a 21-gene
superfamily categorized into 11 families (PDE1–PDE11)
(7). PDE5 is widely expressed in the corpora cavernosa
of the penis, systemic arteries and veins, the pulmonary
arteries, the myocardium, the skeletal muscles, and the
platelets (8,9). Potent and selective PDE5 inhibitors have
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been approved for therapeutic use for erectile dysfunction
(10), pulmonary hypertension (11,12) and Raynaud’s
phenomenon (13). Previous studies reported that a longacting PDE5 inhibitor, tadalafil, is beneficial in ischemic
injury of neurons, ovary, myocardium, kidney, and liver
via preventing ROS damage, lipid peroxidation, and
apoptosis and restoring antioxidant levels (14–18). Chronic
treatment of diabetic rats with tadalafil improved redox
signaling by enhancing the antioxidant enzyme glutathione
S-transferase kappa-1 and downregulated redox regulatory
chaperones, heat shock protein 8, and 75 kDa glucose
regulatory protein (19). Koka et al. (16) demonstrated that
chronic treatment with tadalafil attenuated oxidative stress
and improved mitochondrial integrity in mice with type 2
diabetes. In another study, tadalafil at a dose of 10 mg/kg
ameliorated circulating inflammatory cytokines, reversed
oxidant/antioxidant dysfunction, and thus protected renal
tissue from Escherichia coli-induced acute pyelonephritis
in rats (20). In 36 patients (age range: 37–59 years) with
clinically documented mild to severe erectile dysfunction,
tadalafil citrate protected the cardiovascular system by
reducing serum levels of oxidative stress (21).
The present study was designed aiming to examine
the effect of tadalafil on the severity of joint and muscle
damage in rats subjected to adjuvant-induced arthritis
(AA).
2. Materials and methods
2.1. Animals and chemicals
Male Sprague Dawley rats (300–450 g) were allowed to
acclimatize for a week before the experiments were started.
They were housed under standard laboratory conditions
(room temperature: 20–26 °C; relative humidity: 40%–
60%; free access to water and food) and maintained on
a 12-h light–12-h dark cycle. The study protocol was
approved by Marmara University School of Medicine,
Animal Care and Use Committee. The experimental
procedures were conducted in accordance with the Guide
to the Care and Use of Laboratory Animals.
2.2. Experimental protocol
The rats were randomly allocated into four groups (n
= 8 per group). To induce AA, the rats were inoculated
intradermally into the plantar surface of the right hind
paw with 0.1 mL of complete Freund’s adjuvant (CFA)
(Sigma, St. Louis, MO, USA) containing 10 mg/mL of
heat-killed Mycobacterium tuberculosis suspended in
paraffin oil (AA group) (22). The control rats were injected
with paraffin oil (0.1 mL) (control group). In the treatment
groups, the rats with AA were treated with tadalafil (Tork,
20 mg per tablet, Bilim İlaç, Turkey) (10 mg/kg; per oral)
once daily between day 5 and day 15 after immunization
(AA + tadalafil group). In another group, the rats with
AA received the soluble guanylate cyclase inhibitor 1H-
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[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 10 mg/
kg; intraperitoneally) (Sigma) 30 min before tadalafil
injection on day 15 (AA + ODQ + tadalafil group).
The doses of tadalafil and ODQ used in this study were
demonstrated to be effective in previous studies (23,24).
Tadalafil tablets were crushed and suspended in water.
ODQ stock solution was prepared in dimethyl sulfoxide
30% v/v in saline.
All rats were decapitated on day 16. Blood samples
were collected and centrifuged at 3000 rpm for 15 min.
Serums were stored at –80 °C for the assessment of total
oxidant status and antioxidant capacity. The left hind paw
was amputated at the ankle. The left metatarsophalangeal
joint and gastrocnemius muscle were dissected. The
gastrocnemius muscle was weighed. Both joint and
muscles were fixed in 10% buffered formaldehyde for
histopathological evaluation. Gastrocnemius muscle
samples were stored at –80 °C for subsequent measurement
of malondialdehyde (MDA) level and glutathione content.
Formation of ROS in muscle samples was monitored
using the Chemiluminescence (CL) method.
2.3. Evaluation of arthritis
Arthritis development was evaluated daily, as described
previously (26). Briefly, the hind ankle circumference was
determined by measuring the laterolateral diameter (a)
and the anteroposterior diameter (b) with digital calipers
and was calculated using the following formula (25):
Circumference (mm) = 2π (√(a2 + b2)/2)
2.4. Histological examination of the metatarsophalangeal
joint and gastrocnemius muscle
Metatarsophalangeal joint and gastrocnemius muscle
samples were placed in 10% formaldehyde. Joint
samples were kept in a decalcifier solution (Osteomoll,
Merck KGaA, Darmstadt, Germany) for 5 days. Both
joint and muscle samples were dehydrated in ascending
alcohol series (70%, 90%, 96%, and 100%) and embedded
in paraffin. For each animal, four randomly taken tissue
sections (5 µm) were stained with hematoxylin and eosin
and Masson’s trichrome. From each section, a minimum of
three areas were randomly selected for histopathological
examination and visualized with a microscope (Olympus
BX51, Tokyo, Japan).
The metatarsophalangeal joints were histologically
scored for inflammation, cartilage damage, pannus
formation, and bone resorption using the criteria
described in Table 1 (26).
Gastrocnemius muscle samples were examined
considering disorganization and degeneration of muscle
fibers, and inflammatory cell infiltration.
Histopathological examinations were performed
by experienced histologists who were unaware of the
treatment groups.
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Table 1. Histopathology scoring criteria used for the evaluation of metatarsophalangeal joints.
Score

Inflammation

Pannus formation

Cartilage damage

Bone resorption

0

None present

None present

None present

None present

1

Minimal infiltration in
periarticular tissue

Minimal infiltration of
pannus in cartilage and
subchondrial bone

Minimal damage

Small areas of resorption

2

Mild infiltration

Mild infiltration
(<1/4 of tibia at edges)

Focal chondrocyte loss

More numerous areas of resorption

3

Moderate inflammation
with moderate edema

Moderate infiltration
(1/4 to 1/3 of tibia affected)

Mid zone chondrocyte
loss

Resorption of medullary trabecular
and cortical bone

4

Marked infiltration with
marked edema

Marked infiltration (1/2 to
3/4 of tibia affected)

Deep zone chondrocyte
loss

Full thickness defects in cortical
bone, marked loss of medullary
bone, 1/2 to 3/4 of tibia affected

5

Severe infiltration with
severe edema

Severe infiltration (>3/4 of
tibia affected)

Severe chondrocyte loss

Full thickness defects in cortical
bone, marked loss of medullary
bone, >3/4 of tibia affected

2.5. Measurement of malondialdehyde (MDA) and
glutathione levels
Gastrocnemius muscle MDA and glutathione levels were
measured in samples homogenized in 10 volumes of icecold 10% trichloroacetic acid by spectrophotometric
methods, as described previously (27,28).
2.6. CL assay
Luminescence of the gastrocnemius muscle homogenates
was recorded using a Mini Lumat LB 9506 luminometer
(EG&G Berthold, Germany) in the presence of luminol or
lucigenin 0.2 mM each. The results were expressed as area
under the curve (AUC) of relative light unit (rlu) for 5 min
per mg tissue (29).
2.7. Serum total oxidant status (TOS) and total
antioxidant capacity (TAC) assays
Measurement of TOS level is based on the oxidation of
ferrous ion to ferric ion in the presence of various oxidative
species in acidic medium and the measurement of the
ferric ion by xylenol orange (30). As described by Erel (31),
TAC assay is based on the bleaching of the characteristic
color of the more stable 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) radical cation by antioxidants.
Measurements were performed using commercial kits (Rel
Assay Diagnostics, Gaziantep, Turkey) via an autoanalyzer
(PG Instruments Ltd, Leicestershire, UK). TOS and TAC
results are expressed as mmol H2O2 equivalent per liter
of serum and mmol Trolox equivalent per liter of serum,
respectively.
2.8. Statistical analysis
Data are expressed as mean ± SEM. The histological data
were compared by Mann–Whitney U nonparametric test.
Other parameters were compared using one-way analysis

of variance (ANOVA) followed by Tukey–Kramer multiple
comparison tests. Values of P < 0.05 were regarded as
significant. Calculations were done using the statistical
analysis package Instat (GraphPad Software, San Diego,
CA, USA).
3. Results
3.1. Evaluation of arthritis
Evaluation of the arthritis severity on day 16 revealed
significantly increased ankle circumference in AA rats
compared to the controls (34.76 ± 0.93 mm vs. 31.28 ±
0.14 mm; P < 0.01). Treatment of AA rats with tadalafil
failed to protect the tissue from edema formation as the
ankle circumference was even higher (37.79 ± 0.60 mm; P
< 0.05) compared to the untreated AA group.
No significant difference was observed between the
experimental groups in terms of gastrocnemius muscle
weight (data not shown).
3.2. Microscopic evaluation of the metatarsophalangeal
joint and gastrocnemius muscle
Histopathological examination of the metatarsophalangeal
joint sections showed thinning of articular cartilage,
disorganization of cartilage surface, increased
inflammatory cell infiltration, desquamation of synovial
epithelium, and increased vascularization in the AA
group. In the tadalafil-treated AA group, the joint samples
revealed regular morphology of the cartilage with slight
destruction, with less inflammatory cell infiltration and
vascularization in comparison to the untreated group.
ODQ given prior to tadalafil did not change the extent
of joint injury in comparison to the tadalafil-treated AA
group (Figure 1).
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Figure 1. Micrographs illustrating the histological appearances of metatarsophalangeal joint samples from the experimental
groups. Articular cartilage and sinovial structure with regular morphology in the control group (A), thinning of articular
cartilage, disorganization of cartilage surface (arrow), increased inflammatory cell infiltration (arrowhead), desquamation
of synovial epithelium (*), and increased vascularization (V) in the AA group (B), regular cartilage morphology with partial
disorganization of cartilage surface (arrow), slight disorganization of synovial epithelium (*), slightly increased vascularization
(V) with minimal inflammatory cell infiltration (arrow head) in the AA + tadalafil group (C) and AA + ODQ + tadalafil group
(D). A1, B1, C1, and D1, H&E staining; A2, B2, C2, and D2, Masson’s trichrome staining. Original magnification 100×; insets:
400×. AA, adjuvant arthritis; ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.

In agreement with these data, in the tadalafil-treated
AA group, the microscopic score was lower compared to
that of the untreated AA group (1.17 ± 0.31 vs. 4.17 ± 0.79;
P < 0.01). ODQ administration did not change tadalafil’s
effect on this parameter (1.15 ± 0.34) (Table 2).
Gastrocnemius muscle sections demonstrated regular
morphology in all experimental groups (Figure 2).
3.3. Gastrocnemius muscle MDA, glutathione, and CL
levels
The AA group presented increased gastrocnemius
muscle MDA (P < 0.01) and glutathione (P < 0.05) levels
compared to the control group. In the tadalafil-treated AA
Table 2. Metatarsophalangeal joint histopathological scores of
the experimental groups. Data are expressed as mean ± S.E.M.
Microscopic score
Control group (n = 8)

0.02 ± 0.01

AA group (n = 8)

4.17 ± 0.01***

AA + treatment groups
Tadalafil (n = 8)

1.17 ± 0.31**++

ODQ + tadalafil (n = 8)

1.15 ± 0.34*++

*P < 0.05, **P < 0.01, ***P < 0.001, vs. control group.++P < 0.01,
vs. AA group.
AA, adjuvant arthritis; ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]
quinoxalin-1-one.
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group, these parameters did not seem to change significantly
compared to the untreated AA group. Muscle MDA level
showed further elevations when ODQ was administered
prior to tadalafil (P < 0.01) (Table 3).
As demonstrated in Figures 3 and 4, gastrocnemius
muscle luminol- and lucigenin-enhanced CL levels showed
significant elevations in the AA group (13.17 ± 2.44 rlu/
mg and 10.69 ± 1.43 rlu/mg, respectively) compared to the
control group (5.30 ± 0.62 rlu/mg and 6.00 ± 0.95 rlu/mg,
respectively) (P < 0.01, for luminol; P < 0.05, for lucigenin).
Tadalafil treatment was effective to reduce these values back
to control levels (4.48 ± 1.12 rlu/mg and 3.04 ± 0.33 rlu/mg)
(P < 0.01, for luminol; P < 0.001, for lucigenin). ODQ given
prior to tadalafil did not change the effect of tadalafil on
these parameters.
3.4. Serum TOS and TAC data
Although the increase in serum TOS level in the AA
group (37.85 ± 5.63 mmol H2O2 Equiv/L) did not reach a
statistically significant level compared to the control group,
tadalafil administration to AA rats decreased serum TOS
levels (21.16 ± 2.43 mmol H2O2 Equiv/L). Serum TOS levels
were comparable among tadalafil- or ODQ + tadalafiltreated AA rats (Table 4).
There were no significant differences between the groups
in terms of serum TAC levels (Table 4).
4. Discussion
CFA-induced rat arthritis shows clinical and pathological
similarity to human rheumatoid arthritis and is the
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Figure 2. Micrographs illustrating the histological appearances of gastrocnemius muscle samples from the experimental
groups. The control group (A), AA group (B), AA + tadalafil group (C), and AA + ODQ + tadalafil group (D) reveal regular
striated muscle morphology in terms of muscle organization and fibers. H&E staining. Original magnification 100×; insets:
400×. AA, adjuvant arthritis; ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
Table 3. Gastrocnemius muscle malondialdehyde (MDA) and glutathione
levels of the experimental groups. Data are expressed as mean ± SEM.
MDA (nmol/g)

Glutathione (µmol/g)

Control group (n = 8)

1.52 ± 0.27

0.34 ± 0.03

AA group (n = 8)

6.60 ± 1.26**

0.75 ± 0.08*

Tadalafil (n = 8)

6.86 ± 1.13

0.65 ± 0.05

ODQ + tadalafil (n = 8)

25.81 ± 5.98

AA + treatment groups
++##

0.65 ± 0.14

*P < 0.05, **P < 0.01 vs. control group,++P < 0.01 vs. AA group. ##P < 0.01 vs.
AA + tadalafil group.
AA, adjuvant arthritis; ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.

most widely used animal model (32). Our study results
demonstrated damage to the metatarsophalangeal joint and
increased ROS production in the gastrocnemius muscle
following intradermal inoculation of CFA into the right hind

paw of rats and partial protection by tadalafil, a long-acting
PDE5 inhibitor, given at a dose of 10 mg/kg for 10 days.
Evaluation of the left ankle at microscopic and
microscopic levels following CFA inoculation revealed
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Figure 3. Luminol-enhanced chemiluminescence (CL) levels of
the gastrocnemius muscle samples from experimental groups (n
= 8 per group). Data are expressed as mean ± SEM. **P < 0.01, vs.
control group; ++P < 0.01, +++P < 0.001, vs. AA group. AA, adjuvant
arthritis; ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.

Figure 4. Lucigenin-enhanced chemiluminescence (CL) levels
of the gastrocnemius muscle samples from experimental groups
(n = 7–8 per group). Data are expressed as mean ± SEM. *P <
0.05, vs. control group; ++P < 0.01, +++P < 0.001, vs. AA group.
AA, adjuvant arthritis; ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]
quinoxalin-1-one.

increased ankle circumference (indicating edema),
thinning of articular cartilage, disorganization of
cartilage surface, increased inflammatory cell infiltration,
desquamation of synovial epithelium, and increased
vascularization. Recent research on CFA-induced arthritis
suggests a role of oxidative stress in the pathophysiology
(33). The role of ROS—derived from macrophages,
lymphocytes, neutrophils, and endothelial cells at the site—
has been studied in the pathophysiology of inflammatory
synovitis (34). ROS comprise the cell membrane or
organelles via oxidation of polyunsaturated fatty acids.
Lipid peroxidation causes loss of membrane fluidity and
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impairs ion transport and membrane integrity, leading
to loss of cellular functions (35). Prior studies reported
increased lipid peroxidation in patients with rheumatoid
arthritis (36) and in plasma of rats with CFA-induced
arthritis (37). MDA is a major oxidative degradation
product of membrane unsaturated fatty acid and is used
as an indicator of lipid peroxidation. In our study, we
observed increased MDA levels in the gastrocnemius
muscle samples from rats with AA.
The body possesses antioxidant defenses, repair
mechanisms, physical defenses, and preventive
mechanisms against ROS-induced oxidative stress.
Endogenous glutathione acts as a free radical scavenger
participating in the metabolism and detoxification of
electrophilic drugs, antioxidant defense, and maintenance
of thiol redox status (38). In our study, rats with AA
had higher gastrocnemius muscle glutathione levels in
comparison to the controls. Increased levels of GSH in AA
might be a defensive response to excessive formation of
ROS and cellular lysis associated with arthritis progression
(39).
CL is a simple and a reproducible technique for
demonstrating the generation of oxidants in tissues. Among
the two CL probes, luminol detects H2O2, hydroxyl radical,
hypochlorite, peroxynitrite, and lipid peroxyl radicals and
lucigenin is particularly sensitive to superoxide radical
(40). It is well known that superoxide radicals play a role
in the degradation of collagen, resulting in the acceleration
of inflammatory reactions and damage to joints through
the activation of cells such as neutrophils (41). During
the course of inflammation, an increase in ROS and
superoxide radicals contributing to lipid peroxidation was
demonstrated in synovial joints (42). In the present study,
we observed increased luminol- and lucigenin-enhanced
CL levels in the gastrocnemius muscle of AA rats. Thus,
increased levels of MDA and glutathione correlate with
increased ROS generation in the gastrocnemius muscle of
AA rats. This demonstrates the presence of oxidant stress
in the muscle tissue in spite of regular morphology in AA
rats.
Although serum concentrations of different oxidant
species and antioxidant molecules could be measured
by direct or indirect methods separately, TOS and TAC
assays are generally preferred as they provide an overall
measurement of cumulative oxidative and antioxidant
status. In the present study, we used a colorimetric and
automated method for the measurement of TOS and
TAC, as described by Erel (30,31). In our study, the AA
group presented significantly higher serum TOS values
in comparison to the control group. This finding is in
agreement with the gastrocnemius muscle MDA and CL
data.
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Table 4. Serum total oxidative status (TOS) and total antioxidant capacity (TAC) levels of the
experimental groups. Data are expressed as mean ± SEM.
TOS
(mmol H2O2 Equiv/L)

TAC
(mmol Trolox Equiv/L)

Control group (n = 8)

33.97 ± 3.87

3.72 ± 0.20

AA group (n = 8)

37.85 ± 5.63

3.22 ± 0.17

Tadalafil (n = 8)

21.16 ± 2.43+

3.67 ± 0.16

ODQ + tadalafil (n = 8)

12.54 ± 3.66

3.27 ± 0.30

AA + treatment groups
**++

AA, adjuvant arthritis; ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
**P < 0.01 vs. control group. +P < 0.05, ++P < 0.01 vs. AA group.

There is limited information about the effect of
PDE5 inhibitors on oxidative mechanisms. Sildenafil
has been shown to inhibit ROS formation and protect
against oxidative stress. In the study by Perk et al.
(43), a single 100 mg/kg dose of sildenafil resulted in a
significant increase in erythrocyte superoxide dismutase
and catalase activities in healthy men. In a rat model of
bleomycin-induced lung fibrosis, sildenafil reversed tissue
MDA levels, myeloperoxidase activity, and serum proinflammatory cytokine levels, and preserved glutathione
(44). Similarly, sildenafil citrate (5 mg/kg per day) for
3 days showed significant protection in a rat acetic
acid-induced colitis model via its actions on oxidant/
antioxidant status (45). Tadalafil has a longer half-life, and
greater selectivity for PDE5 than sildenafil (18). In a recent
study by Bektas et al. (18), tadalafil (10 mg/kg) prevented
ROS damage, lipid peroxidation, hepatocyte necrosis,
and apoptosis in rat liver ischemia/reperfusion injury
and minimized liver damage. In a zymosan-induced rat
model of arthritis, tadalafil (0.02–0.5 mg/kg, per oral)
dose-dependently decreased neutrophil influx and tumor
necrosis-alpha release into the synovial cavity (46). In our
study, evaluation of the inflamed joint at microscopic level
showed protection by tadalafil (10 mg/kg; per oral) with no
significant recovery in joint edema. Additionally, tadalafil
administration to AA rats did not cause a significant
change in muscle MDA and glutathione but reduced CL
and plasma TOS.
A clinical study on patients with erectile dysfunction
demonstrated the beneficial action of tadalafil on the

cardiovascular system via restoring serum TOS and TAC
levels. As suggested by the authors, this effect might
be due to prevention of the activity and expression of
nicotinamide adenine dinucleotide phosphate oxidase by
enhancing cyclic GMP levels, which would reduce the
formation of ROS while increasing antioxidant enzymes
(43).
In our study, we also examined whether the effects of
tadalafil would be modified by cGMP blockade. However,
the guanylate cyclase inhibitor ODQ did not change
tadalafil’s actions on AA-induced joint and muscle damage.
Thus, the effects of tadalafil in this model of arthritis do
not seem to be mediated by cGMP.
An in vitro study in our laboratory examined the
superoxide radical scavenging ability of tadalafil in a
xanthine/xanthine oxidase assay. In this study, tadalafil
reduced lucigenin-enhanced luminescence at a dose 0.25
mg/mL (601.3 ± 47.9 rlu vs. 1029.0 ± 124.0 rlu; P < 0.05)
and ODQ did not change this effect (unpublished results).
In conclusion, the results of our study demonstrate
damage to the metatarsophalangeal joint and increased
ROS production in the gastrocnemius muscle in a rat
model of CFA-induced arthritis and partial protection
by the long-acting PDE5 inhibitor tadalafil possibly via
suppression of ROS generation.
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